USMF logo

Institutional Repository in Medical Sciences
of Nicolae Testemitanu State University of Medicine and Pharmacy
of the Republic of Moldova
(IRMS – Nicolae Testemitanu SUMPh)

Biblioteca Stiintifica Medicala
DSpace

University homepage  |  Library homepage

 
 
Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12710/12335
Full metadata record
DC FieldValueLanguage
dc.contributor.authorLates, Gratiana-Andreea-
dc.date.accessioned2020-10-27T08:15:42Z-
dc.date.available2020-10-27T08:15:42Z-
dc.date.issued2020-
dc.identifier.citationLATES, Gratiana-Andreea. The feasibility of sentinel lymph node (SLN) biopsy examination after neoadjuvant chemotherapy for breast cancer patients. In: MedEspera: the 8th Internat. Medical Congress for Students and Young Doctors: abstract book. Chișinău: S. n., 2020, p. 93-94.en_US
dc.identifier.urihttps://medespera.asr.md/wp-content/uploads/ABSTRACT-BOOK.pdf-
dc.identifier.urihttp://repository.usmf.md/handle/20.500.12710/12335-
dc.descriptionGeorge Emil Palade University of Medicine, Pharmacy, Science and Technology of Targu Mures, The 8th International Medical Congress for Students and Young Doctors, September 24-26, 2020en_US
dc.description.abstractIntroduction. The feasibility of sentinel lymph node biopsy examination for breast cancer patients that had no clinically detected lymph nodes and underwent neoadjuvant chemotherapy have been analyzed by injecting blue dye into the area near the tumor. Aim of the study. Axillary status is one of the most important prognostic factors for breast cancer. Sentinel node biopsy has become a standard procedure for axillary staging in clinically node-negative patients. This technique brings out important information that helps physician in therapeutic management of these patients. Lymphadenectomy is an invasive procedure associated with higher morbidity and complications that has shown to be unnecessary in some cases of breast cancer. Materials and methods.. Forty patients with stages 0-II breast cancer treated with neoadjuvant chemotherapy were enrolled in the study. The sentinel node biopsy was performed after blue dye injection into the tumor. Sentinel nodes stained bright blue and were removed. The sentinel nodes have been examined under the microscope for cancer signs. Depending on the biopsy results this was followed or not by lymphadenectomy . Parameters like age, size of tumor, Nottingham grade, presence of hormonal receptors, HER 2 enriche, presence of microcalcification, necrosis and inflammatory infiltrate have been studied to predict the risk of axillary metastasis. Results. Forty patients received SLN biopsy after neoadjuvant chemotherapy. Ten cases (25%) of these had positive sentinel lymph nodes confirmed by anatomopathological examination. Lymphadenectomy procedure have been performed and only 3 of them (30%) had metastatic lymph nodes in the rest of the axilla. Conclusions. SLN biopsy accuracy after neoadjuvant chemotherapy is still debated in literature. Thirty of our patients were saved form an unnecessary axillary lymph node dissection by using SLN biopsy technique.en_US
dc.language.isoenen_US
dc.publisherMedEsperaen_US
dc.subjectbreast canceren_US
dc.subjectneoadjuvant chemotherapyen_US
dc.subjectsentinel nodesen_US
dc.titleThe feasibility of sentinel lymph node (SLN) biopsy examination after neoadjuvant chemotherapy for breast cancer patientsen_US
dc.typeArticleen_US
Appears in Collections:MedEspera 2020

Files in This Item:
File Description SizeFormat 
THE_FEASIBILITY_OF_SENTINEL_LYMPH_NODE_SLN_BIOPSY.pdf444.53 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2013  Duraspace - Feedback